Stephens & Co. Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73

Benzinga Newsdesk www.benzinga.com Negative 81.3%

Neg 81.3% Neu 0% Pos 0%

Stephens & Co. analyst Steven Etoch downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $68 to $73.